Value proposition

Enabling the next generation of medicines

Lentitek is developing solutions to help amazing therapies get to more people.

Gene therapies, and gene-modified cell therapies such as CAR-T are proving themselves as incredible life changing and life saving therapies. However they face an issue with the production yield of the viral vector.

Lentitek is developing solutions to improve the viral yield by 10 fold and beyond. This will help these developers reduce production costs and allow these amazing therapies get into more people who really need it!